Relationship between Telomere Length,
breast cancer telomerase reverse transcriptase (TERT)
expression of transcription factors genes
single nucleotide polymorphism (SNP)
telomere length
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
05 May 2022
05 May 2022
Historique:
received:
06
04
2022
revised:
15
04
2022
accepted:
04
05
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
The molecular mechanisms of telomerase reverse transcriptase (
Identifiants
pubmed: 35563554
pii: ijms23095164
doi: 10.3390/ijms23095164
pmc: PMC9102200
pii:
doi:
Substances chimiques
Sp1 Transcription Factor
0
SP1 protein, human
0
TP53 protein, human
0
Tumor Suppressor Protein p53
0
TERT protein, human
EC 2.7.7.49
Telomerase
EC 2.7.7.49
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Centre for Research and Development
ID : STRATEGMED3/306853
Organisme : National Science Center
ID : 2017/27/B/NZ5/01167
Références
Nucleic Acids Res. 2000 Feb 1;28(3):669-77
pubmed: 10637317
J Natl Cancer Inst. 2021 Oct 1;113(10):1429-1433
pubmed: 33146377
Am J Epidemiol. 2013 Apr 1;177(7):617-24
pubmed: 23444102
Oncotarget. 2016 Aug 30;7(35):56976-56985
pubmed: 27486974
Cancer Causes Control. 2011 Jul;22(7):1061-6
pubmed: 21643930
Genes Chromosomes Cancer. 2013 Jul;52(7):595-609
pubmed: 23629941
Genet Test Mol Biomarkers. 2016 Aug;20(8):459-64
pubmed: 27336831
Cancer Res. 2010 Apr 15;70(8):3170-6
pubmed: 20395204
Br J Cancer. 2007 Sep 17;97(6):832-6
pubmed: 17848914
Mol Biol Rep. 2012 Dec;39(12):10859-63
pubmed: 23065203
Nature. 2000 Nov 16;408(6810):307-10
pubmed: 11099028
Mutagenesis. 2020 Dec 31;35(6):491-497
pubmed: 33367858
Onco Targets Ther. 2019 May 31;12:4309-4320
pubmed: 31239704
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5
pubmed: 16141321
Breast Care (Basel). 2021 Jun;16(3):202-213
pubmed: 34248461
Oncotarget. 2017 May 26;8(40):67203-67217
pubmed: 28978027
Nat Genet. 2013 Apr;45(4):371-84, 384e1-2
pubmed: 23535731
Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):605-13
pubmed: 20142254
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur J Surg Oncol. 2003 May;29(4):321-6
pubmed: 12711283
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1152-6
pubmed: 19293310
Breast Cancer Res Treat. 2010 Apr;120(3):769-75
pubmed: 19543829
Oncotarget. 2017 Apr 25;8(17):28021-28027
pubmed: 28427205
J Cancer Res Ther. 2016 Apr-Jun;12(2):1040-4
pubmed: 27461695
Exp Cell Res. 2020 Nov 1;396(1):112298
pubmed: 32971118
J BUON. 2017 Nov-Dec;22(6):1494-1499
pubmed: 29332343
Cell Mol Biol (Noisy-le-grand). 2018 Feb 28;64(3):108-115
pubmed: 29506639
Oncotarget. 2017 Aug 24;8(44):77540-77551
pubmed: 29100407
Cell. 2017 Sep 7;170(6):1062-1078
pubmed: 28886379
HGG Adv. 2021 Jul 8;2(3):100041
pubmed: 34355204
J Pathol. 2021 Jul;254(4):443-453
pubmed: 33826155
NPJ Breast Cancer. 2021 Apr 16;7(1):43
pubmed: 33863915
Clin Cancer Res. 2014 Jul 1;20(13):3569-80
pubmed: 24803582
Hum Cell. 2021 Jul;34(4):1066-1081
pubmed: 33743166
Nat Genet. 2011 Oct 30;43(12):1210-4
pubmed: 22037553
J Biol Chem. 2008 Aug 29;283(35):23567-80
pubmed: 18586674
Cancer Res. 2008 May 15;68(10):3618-23
pubmed: 18483243
Gene. 2012 May 1;498(2):135-46
pubmed: 22381618
Cancer Cell Int. 2021 Dec 24;21(1):703
pubmed: 34952583
Cancer Res. 2007 Jun 1;67(11):5538-44
pubmed: 17545637
Cancer Genet Cytogenet. 2009 Apr 15;190(2):71-4
pubmed: 19380022
J Pathol. 2014 Apr;232(5):522-33
pubmed: 24374933